A Win For Calithera Biosciences, Inc.

Thu, Sep 26, 2024 at 07:35 PM

Calithera Biosciences, Inc. (CALA:NASDAQ) shot up at $0.03, representing a gain of 50%. From Thu, Sep 12, 2024, the stock recorded 16.67% Up Days and 71.43% Green Days

About Calithera Biosciences, Inc. (CALA:NASDAQ)

Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

Top 10 Gainers:

Fangdd Network Group Ltd. (DUO:NASDAQ), 109.97%
Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
Volato Group Inc. Class A (SOAR:NYSEMKT), 83.21%
Translate Bio, Inc. (TBIO:NASDAQ), 71.98%
Alpha Technology Group Limited (ATGL:NASDAQ), 71.16%
Pasithea Therapeutics Corp. (KTTA:NASDAQ), 52.15%
Calithera Biosciences, Inc. (CALA:NASDAQ), 50%
CN Energy Group Inc. (CNEY:NASDAQ), 39.73%
Nano Labs Ltd (NA:NASDAQ), 33.53%
American Lithium Corp. (AMLI:NASDAQ), 33.33%